Benfluorex 23602-78-0
Benfluorex is an anorectic and hypolipidemic agent. Clinical studies have shown it may improve glycemic control and decrease insulin resistance in people with poorly controlled type 2 diabetes; it is marketed in France as an adjuvant antidiabetic. On 18 December 2009 the European Medicines Agency (EMEA) has recommended the withdrawal of all medicines containing benfluorex in the European Union, because their risks, particularly the risk of heart valve disease (fenfluramine-like cardiovascular side-effects), are greater than their benefits. Benfluorex is structurally related to fenfluramine.
read more [+]| Systematic (IUPAC) name: | (RS)-2-({1-[3-(trifluoromethyl)phenyl]propan- 2-yl}amino)ethyl benzoate |
|---|---|
| Benfluorex CAS number: | 23602-78-0 |
| ATC code: | A10BX06 |
| PubChem: | 2318 |
| DrugBank: | |
| Formula: | C19H20N1O2 |
| Molecular mass: | 351.363 g/mol |
| Benfluorex Assay/Purity: | Typically NLT 98% |
